HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

When the media encourage HIV testing, more people get tested

"Changing behavior is a complex process that involves several factors. Mass media can be used to educate and raise awareness about a topic and can enhance appropriate utilization of health care services," according to lead review author Dr. Janaki Vidanapathirana, of Monash University in Melbourne, Australia.

26 Jul 2005

Research sets foundation for new generation of vaccines for HIV, influenza

Scientists have taken a major step toward the goal of altering viruses, bacteria and tumor cells so that they demand attention from immune cells designed to destroy them.

26 Jul 2005

Molecular link between a viral infection and development of a common and fatal form of liver cancer

Researchers at The University of Texas M. D. Anderson Cancer Center have uncovered a crucial molecular link between a viral infection and development of a common and fatal form of liver cancer. In the process, they have identified a possible way to treat this disease as well as a number of other cancers.

26 Jul 2005

Analysis of the Phase I/II clinical trial of HIV drug candidate PA-457

V.I. Technologies (Vitex) and collaborators at the University at Buffalo's School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, today presented a detailed analysis of the Phase I/II clinical trial of its HIV drug candidate PA-457 at the 3rd International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment in Rio de Janeiro, Brazil.

26 Jul 2005

Variation in HIV's ability to disable host defenses contributes to rapid evolution

One of the reasons HIV is so difficult to contain and treat is its rapid evolution. Understanding how host defenses and viral countermeasures contribute to that evolution is vital.

25 Jul 2005

Discovery of a receptor that appears to function as one "lock" that HSV opens to allow it to enter human cells

It's one of the most common viruses in America, and one that causes the most guilt and shame. It can get inside almost any kind of human cell, reproduce in vast numbers, and linger for years in the body, causing everything from recurrent genital blisters to sores around the mouth. Its complications can kill, and it may increase susceptibility to many nerve and brain disorders.

24 Jul 2005

Crucial molecular link between a hepatitis B virus (HBV) and hepatocellular carcinoma (HCC)

21 Jul 2005

New design for HIV vaccine trials in animals

Emory University researchers have proposed a new design for HIV vaccine trials in animals that would more closely mimic how humans are exposed to the virus - potentially giving AIDS researchers a more effective tool in developing successful treatments to prevent HIV infection.

20 Jul 2005

Combination of ribavirin and interferon is more effective in treating hepatitis C than using interferon alone

The researchers reviewed 72 randomized trials and 9,991 patients who had chronic hepatitis C for more than six months and were previously untreated, who had relapsed after treatment or who had not responded to other treatment.

19 Jul 2005

FDA fast tracks HIV protease inhibitor from Vertex and GSK

Vertex Pharmaceuticals has announced that its collaborator, GlaxoSmithKline (GSK), has received fast track designation for the HIV protease inhibitor (PI) 640385 (VX-385) from the United States Food and Drug Administration.

19 Jul 2005

Moving towards a cheap and easy way to monitor HIV/AIDS

Doctors regularly monitor the level of an immune cell in the blood called a CD4 cell in HIV-infected individuals, to decide when to start treatment and when to change medications.

19 Jul 2005

Discrimination of people living with HIV/AIDS in Nigeria

People living with HIV/AIDS face many forms of stigma and discrimination. This is the case in whichever country they may live, as has been shown in a number of previous research studies.

19 Jul 2005

Activist groups hinder important clinical trials of HIV medication

One promising approach to help stem the global HIV epidemic is to give commercial sex workers an HIV medication (such as the drug tenofovir) before they have high risk sex in the hope of reducing their chances of becoming infected, an approach called "pre-exposure prophylaxis" (PREP).

19 Jul 2005

First generation of HIV vaccines may be available within 10 years but availability doesn't guarantee uptake

Public health officials must be sensitive to concerns about stigma and fear of vaccine-induced infection if they want women to take advantage of HIV vaccines now under development, says a University of Toronto researcher.

18 Jul 2005

Close connection between gender-based violence and HIV infection

amfAR has released an issue brief demonstrating a close connection between gender-based violence and HIV infection. The New York-based AIDS research foundation is calling for resources to develop, test, and implement behavioral, biomedical, and social interventions to address violence as both a cause and a consequence of HIV infection.

18 Jul 2005

Ranbaxy receives tentative FDA approval to manufacture and market Zidovudine tablets

India's Ranbaxy Laboratories has announced that it has received tentative approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Zidovudine Tablets USP, 300 mg.

15 Jul 2005

Police shooting of AIDS protesters by South African police

AIDS Healthcare Foundation (AHF) today expressed its profound outrage over the unprovoked attack -- including what is believed to be the first-ever police shooting of AIDS protesters anywhere worldwide -- by South African police on AIDS activists conducting a peaceful protest.

15 Jul 2005

Scientists have identified the first reported case in Asia of primate-to-human transmission of simian foamy virus

...a retrovirus found in macaques and other primates that so far has not been shown to cause disease in humans.

13 Jul 2005

South Africa now 2nd only to India in HIV/AIDS cases

New figures from the South African Department of Health say more than 6.5 million of the country's 47 million people may now be HIV-positive.

12 Jul 2005

Sirna Therapeutics granted new UK patents

Sirna Therapeutics has announced that the United Kingdom (UK) Patent Office has granted the Company two additional short interfering RNA (siRNA) target patents. The first patent covers any siRNA with one or more chemical modifications targeting Vascular Endothelial Growth Factor (VEGF).

12 Jul 2005

HIV/AIDS News and Research

Further Reading

When the media encourage HIV testing, more people get tested

Research sets foundation for new generation of vaccines for HIV, influenza

Molecular link between a viral infection and development of a common and fatal form of liver cancer

Analysis of the Phase I/II clinical trial of HIV drug candidate PA-457

Variation in HIV's ability to disable host defenses contributes to rapid evolution

Discovery of a receptor that appears to function as one "lock" that HSV opens to allow it to enter human cells

Crucial molecular link between a hepatitis B virus (HBV) and hepatocellular carcinoma (HCC)

New design for HIV vaccine trials in animals

Combination of ribavirin and interferon is more effective in treating hepatitis C than using interferon alone

FDA fast tracks HIV protease inhibitor from Vertex and GSK

Moving towards a cheap and easy way to monitor HIV/AIDS

Discrimination of people living with HIV/AIDS in Nigeria

Activist groups hinder important clinical trials of HIV medication

First generation of HIV vaccines may be available within 10 years but availability doesn't guarantee uptake

Close connection between gender-based violence and HIV infection

Ranbaxy receives tentative FDA approval to manufacture and market Zidovudine tablets

Police shooting of AIDS protesters by South African police

Scientists have identified the first reported case in Asia of primate-to-human transmission of simian foamy virus

South Africa now 2nd only to India in HIV/AIDS cases

Sirna Therapeutics granted new UK patents

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News